CLDN2 and endometrioid adenocarcinoma: By evaluating immunohistochemical scores, low claudin-1 and high claudin-2 protein contents were found in hyperplasia and endometrioid adenocarcinoma (type I), whereas in seropapillary adenocarcinoma (type II), high claudin-1 and low claudin-2 levels were detected [35].